T2 BIOSYSTEMS ($TTOO) is expected to release its quarterly earnings data on Friday, June 6th before market open, per Finnhub. Analysts are expecting revenue of $4,488,000 and earnings of -$0.49 per share.
You can see Quiver Quantitative's $TTOO stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
T2 BIOSYSTEMS Hedge Fund Activity
We have seen 2 institutional investors add shares of T2 BIOSYSTEMS stock to their portfolio, and 29 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARMISTICE CAPITAL, LLC removed 1,396,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $586,320
- VANGUARD GROUP INC removed 154,814 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $19,042
- GEODE CAPITAL MANAGEMENT, LLC removed 142,196 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $17,490
- UBS GROUP AG removed 139,240 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $17,126
- SQUAREPOINT OPS LLC removed 92,983 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $11,436
- BLACKROCK, INC. removed 76,827 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $9,449
- STATE STREET CORP removed 63,743 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $7,840
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
